Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: A systematic review and meta-analysis

International Journal of Cancer

Volumn 130, Issue 9, 2012, Pages 2155-2163

  Gu, Jinyang ^a,b   Bai, Jianling ^c   Shi, Xiaolei ^a,b   Zhou, Jianxin ^a,b   Qiu, Yudong ^a,b   Wu, Yafu ^a,b   Jiang, Chunping ^a,b   Sun, Xitai ^a,b   Xu, Fanggui ^c   Zhang, Yue ^c   Ding, Yitao ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Jiangsu Province's Key Medical Center for Hepatobiliary Disease   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cholangiocarcinoma; extended bile duct resection; liver transplantation; meta analysis; neoadjuvant therapy; systematic review

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; BILE DUCT CANCER; BILE DUCT CARCINOMA; BILE LEAKAGE; BILIARY TRACT SURGERY; CANCER PATIENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); HUMAN; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; META ANALYSIS (TOPIC); PANCREAS DISEASE; PATIENT SAFETY; PERCUTANEOUS TRANSHEPATIC DRAINAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; VASCULAR DISEASE;

ADULT; BILE DUCT NEOPLASMS; CHEMORADIOTHERAPY; CHOLANGIOCARCINOMA; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84862809575     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26019     Document Type: Review

References (50)

1. Aljiffry M, Walsh MJ, Molinari M,. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15: 4240-62.
2. Cho SY, Park SJ, Kim SH, Han SS, Kim YK, Lee KW, Lee SA, Hong EK, Lee WJ, Woo SM,. Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol 2010; 17: 1823-30.
3. Morris-Stiff G, Bhati C, Olliff S, Hübscher S, Gunson B, Mayer D, Mirza D, Buckels J, Bramhall SR,. Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience. Dig Surg 2008; 25: 126-32.
4. Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB, Bain VG,. Cholangiocarcinoma: has there been any progress? Can J Gastroenterol 2010; 24: 52-7.
5. Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16: 262-78.
6. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM,. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006; 202: 275-83.
7. Goldstein RM, Stone M, Tillery GW, Senzer N, Levy M, Husberg BS, Gonwa T, Klintmalm G,. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993; 166: 768-71.
8. Lang H, Sotiropoulos GC, Kaiser GM, Molmenti EP, Malagõ M, Broelsch CE,. The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2005; 7: 268-72.
9. Jonas S, Neuhaus P,. The perspective of liver transplantation for cholangiocarcinoma. Liver Transpl 2007; 13: 1358-61.
10. Schwartz JJ, Hutson WR, Gayowski TJ, Sorensen JB,. Liver transplantation for cholangiocarcinoma. Transplantation 2009; 88: 295-8.
11. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B,. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224: 628-38.
12. Robles R, Figueras J, Turriõn VS, Margarit C, Moya A, Varo E, Calleja J, Valdivieso A, Valdecasas JC, Lõpez P, Gõmez M, de Vicente E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004; 239: 265-71.
13. Becker NS, Rodriguez JA, Barshes NR, O'Mahony CA, Goss JA, Aloia TA,. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg 2008; 12: 117-22.
14. Jeyarajah DR, Klintmalm GB,. Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg 1998; 5: 48-51.
15. Pinson CW, Moore DE,. Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 2003; 5: 203-5.
16. De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG, Burgart L, Gores GJ,. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309-16.
17. Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B, Jr, McCashland T, Sorrell M, Tempero M, Langnas A,. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002; 2: 774-9.
18. Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ,. Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 2009; 18: 325-37.
19. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.0.1. The Cochrane Collaboration; 2008. Available at: www.cochrane-handbook.org. Accessed on July 2, 2009.
20. Stuart A, Ord J,. Kendall's advanced theory of statistics, 6th ed. London: Edward Arnold, 1994.
21. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
22. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R,. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997; 79: 26-34.
23. Iwatsuki S, Todo S, Marsh JW, Madariaga JR, Lee RG, Dvorchik I, Fung JJ, Starzl TE,. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187: 358-64.
24. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R,. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230: 808-18.
25. Shimoda M, Farmer DG, Colquhoun SD, Rosove M, Ghobrial RM, Yersiz H, Chen P, Busuttil RW,. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 2001; 7: 1023-33.
26. Lindnér P, Norrby J, Olausson M, Rizell M, Cahlin C, Friman S,. Survival after liver transplantation for cholangiocarcinoma has increased during the last decade. Transplant Proc 2003; 35: 811-12.
27. Ghali P, Marotta PJ, Yoshida EM, Bain VG, Marleau D, Peltekian K, Metrakos P, Deschênes M,. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. Liver Transpl 2005; 11: 1412-16.
28. Zheng SS, Shi QF, Liang TB, Wu J, Wang WL, Shen Y, Zhang M,. Orthotopic liver transplantation for patients with Klatskin tumor. Hepatobiliary Pancreat Dis Int 2005; 4: 28-31.
29. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W, Nyberg SL, Ishitani MB, Rosen CB,. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 82: 1703-7.
30. Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP,. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol 2008; 34: 787-94.
31. Mantel HT, Rosen CB, Heimbach JK, Nyberg SL, Ishitani MB, Andrews JC, McKusick MA, Haddock MG, Alberts SR, Gores GJ,. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 2007; 13: 1372-81.
32. Kaiser GM, Sotiropoulos GC, Jauch KW, Löhe F, Hirner A, Kalff JC, Königsrainer A, Steurer W, Senninger N, Brockmann JG, Schlitt HJ, Zülke C, et al. Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc 2008; 40: 3191-3.
33. Wu Y, Johlin FC, Rayhill SC, Jensen CS, Xie J, Cohen MB, Mitros FA,. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 2008; 14: 279-86.
34. Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, Pratschke J, Jonas S, Neuhaus P,. Extended bile duct resection liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl 2009; 15: 1499-507.
35. Kornberg A, Küpper B, Thrum K, Wilberg J, Sappler A, Gottschild D,. Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET. Am J Transplant 2009; 9: 2631-6.
36. Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, Gaudio E, Alvaro D,. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 2010; 42: 253-60.
37. Jonas S, Benckert C, Thelen A, Lopez-Hänninen E, Rösch T, Neuhaus P,. Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol 2008; 34: 263-71.
38. Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW,. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997; 225: 472-81.
39. Starzl TE, Fung JJ,. Themes of liver transplantation. Hepatology 2010; 51: 1869-84.
40. Alessiani M, Tzakis A, Todo S, Demetris AJ, Fung JJ, Starzl TE,. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995; 180: 1-9.
41. He XS, Zhang S, Zhu XF, Wang DP, Ma Y, Wang GD, Ju WQ, Wu LW, Huang JF,. Orthotopic liver transplantation with hepatopancreatoduodenectomy for hilar cholangiocarcinoma. Chin Med J (Engl) 2007; 120: 251-3.
42. Varotti G, Gondolesi GE, Roayaie S, Suriawinata A, Soltys K, Fishbein TM, Schwartz ME, Miller C,. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg 2003; 197: 765-9.
43. Hubert C, Fervaille C, Sempoux C, Horsmans Y, Humblet Y, Machiels JP, Zech F, Ceratti A, Gigot JF,. Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases. Surgery 2010; 147: 185-94.
44. Abdalla EK, Vauthey JN,. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Dig Surg 2008; 25: 421-9.
45. Castro Beza I, Sánchez Ruiz J, Peracaula Espino FJ, Villanego Beltrán MI,. Drug-related hepatotoxicity and hepatic failure following combined androgen blockade. Clin Transl Oncol 2008; 10: 591-2.
46. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB,. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24: 201-7.
47. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM,. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242: 451-8.
48. Heimbach J,. Hilar cholangiocarcinoma and liver transplantation. Transplantation 2009; 88: 299-300.
49. Heimbach JK,. Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 2008; 24: 384-8.
50. Rosen CB, Heimbach JK, Gores GJ,. Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford) 2008; 10: 186-9.